Patent US6262247B1 successfully refreshed from Google Patents.
← Back to Patent Explorer
US6262247B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Polycyclic aromatic hydrocarbon induced molecules

Assignee: Incyte Corp
•
Filing: 1999-08-30
•
Granted: 2001-07-17
•
Expires: 2019-08-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention provides novel nucleic acid molecules and encoded proteins associated with response to polycyclic aromatic hydrocarbon exposure. The invention also provides expression vectors, host cells, and antibodies. The invention also provides methods for screening or purifying ligands and diagnosing, treating or preventing disorders associated with polycyclic aromatic hydrocarbon exposure.

Inventors

  • 👤 Matthew R. Kaser
  • 👤 Yalda Azimzai
  • 👤 Henry Yue

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 22:36
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/46; C07K14/47; A; A61; A61P; A61P35/00; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6876; C12Q1/6883; A61K; A61K38/00; C12Q2600/00; C12Q2600/142; C12Q2600/158

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 90 words
A substantially purified nucleic acid molecule expressed in response to polycyclic aromatic hydrocarbon exposure comprising: (a) a nucleic acid molecule encoding a protein selected from SEQ ID NOs:7, 8 and 14; (b) a nucleic acid molecule selected from the group consisting of SEQ ID NOs:1-5 and 9-13; or (c) a nucleic acid molecule which is the complement of the nucleic acid molecule of (a) or (b) wherein each and every nucleotide of the complement is complementary to each and every nucleotide of the nucleic acid molecule of (a) or (b).
Claim 2
Dependent Claim 90 words
A substantially purified nucleic acid molecule expressed in response to polycyclic aromatic hydrocarbon exposure comprising: (a) a nucleic acid molecule encoding a protein selected from SEQ ID NOs:7, 8 and 14; (b) a nucleic acid molecule selected from the group consisting of SEQ ID NOs:1-5 and 9-13; or (c) a nucleic acid molecule which is the complement of the nucleic acid molecule of (a) or (b) wherein each and every nucleotide of the complement is complementary to each and every nucleotide of the nucleic acid molecule of (a) or (b).
Claim 3
Dependent Claim 13 words
A composition comprising at least one nucleic acid molecule of claim 1 .
Claim 4
Dependent Claim 12 words
An expression vector comprising the nucleic acid molecule of claim 1 .
Claim 5
Dependent Claim 11 words
A host cell comprising the expression vector of claim 3 .
Claim 6
Dependent Claim 32 words
A method for producing a protein, the method comprising: (a) culturing the host cell of claim 4 under conditions for expression of the protein; and (b) recovering the protein from cell culture.
Claim 7
Dependent Claim 64 words
A substantially purified nucleic acid molecule expressed in response to polycyclic aromatic hydrocarbon exposure comprising: (a) a nucleic acid molecule encoding a protein of SEQ ID NOS:6; or (b) a nucleic acid molecule which is the complement of the nucleic acid molecule of (a) wherein each every nucleotide of the complement is complementary to each every nucleotide of the nucleic acid molecule of (a).
Claim 8
Dependent Claim 64 words
A substantially purified nucleic acid molecule expressed in response to polycyclic aromatic hydrocarbon exposure comprising: (a) a nucleic acid molecule encoding a protein of SEQ ID NOS:6; or (b) a nucleic acid molecule which is the complement of the nucleic acid molecule of (a) wherein each every nucleotide of the complement is complementary to each every nucleotide of the nucleic acid molecule of (a).
Claim 9
Dependent Claim 11 words
A composition comprising the nucleic acid molecule of claim 6 .

References Cited (Backward Citations)

WO1999006439A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2004-07-16 2005-01-15 2005-07-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2008-07-16 2009-01-15 2009-07-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2012-07-16 2013-01-15 2013-07-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag